Perspectives of US Adults on Antimicrobial Trials With Noninferiority Designs

JAMA Netw Open. 2023 May 1;6(5):e2316297. doi: 10.1001/jamanetworkopen.2023.16297.

Authors

Robert Morlock¹, John Rose², John H Powers 3rd³

Affiliations

¹ Acumen Health Research Institute, Ann Arbor, Michigan.
² Institute for Transport and Logistics Studies, The University of Sydney Business School, Sydney, New South Wales, Australia.
³ Department of Medicine, George Washington University School of Medicine, Washington, DC.

No abstract available

Plain language summary

This survey study assesses respondents’ willingness to participate in noninferiority trials of antimicrobials.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Anti-Infective Agents*
Humans
Research Design

Substances

Anti-Infective Agents